Jane J. Zara

Array ( [id] => 7743370 [patent_doc_number] => 20120021516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'NOVEL STRUCTURALLY DESIGNED shRNAs' [patent_app_type] => utility [patent_app_number] => 13/252784 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021516.pdf [firstpage_image] =>[orig_patent_app_number] => 13252784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221321 [patent_doc_number] => 20120135521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'ANTIGENE LOCKS AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/247366 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27625 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13247366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228644 [patent_doc_number] => 20120142754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'MODULATION OF TIMP1 AND TIMP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/246621 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 73150 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 126 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228644 [patent_doc_number] => 20120142754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'MODULATION OF TIMP1 AND TIMP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/246621 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 73150 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 126 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738302 [patent_doc_number] => 08410072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Use of a growth-stimulating protein' [patent_app_type] => utility [patent_app_number] => 13/246696 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 32 [patent_no_of_words] => 11829 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122547 [patent_doc_number] => 09156898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Treatment of cancer and compositions' [patent_app_type] => utility [patent_app_number] => 13/243914 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13475 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13243914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8174169 [patent_doc_number] => 20120108799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Modifications for Antisense Compounds' [patent_app_type] => utility [patent_app_number] => 13/227286 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16733 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108799.pdf [firstpage_image] =>[orig_patent_app_number] => 13227286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11583115 [patent_doc_number] => 09637742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Nucleic acid molecules inducing RNA interference, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/880670 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 7137 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808093 [patent_doc_number] => 20120059047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/220568 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 73486 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059047.pdf [firstpage_image] =>[orig_patent_app_number] => 13220568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784792 [patent_doc_number] => 20120046348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'OLIGONUCLEOTIDE CHELATE COMPLEXES' [patent_app_type] => utility [patent_app_number] => 13/212306 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 16745 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046348.pdf [firstpage_image] =>[orig_patent_app_number] => 13212306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055321 [patent_doc_number] => 20130253035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'CAMKK-BETA AS A TARGET FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/817382 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 16608 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607992 [patent_doc_number] => 08785157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Method for using ref protein as a targeted reca-dependent nuclease' [patent_app_type] => utility [patent_app_number] => 13/208985 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14227 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13208985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807139 [patent_doc_number] => 20120058092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'PROCESS FOR THE PREPARATION OF A COMPOSITION OF GENETICALLY MODIFIED HEMATOPOIETIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 13/206301 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 34198 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058092.pdf [firstpage_image] =>[orig_patent_app_number] => 13206301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401730 [patent_doc_number] => 08691782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton' [patent_app_type] => utility [patent_app_number] => 13/254159 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 29 [patent_no_of_words] => 39356 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302044 [patent_doc_number] => 20120184601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'ANTIVIRAL OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/182548 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 37675 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720936 [patent_doc_number] => 20120010271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/254150 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39198 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010271.pdf [firstpage_image] =>[orig_patent_app_number] => 13254150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903669 [patent_doc_number] => 20130171172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES' [patent_app_type] => utility [patent_app_number] => 13/807089 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8312 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511539 [patent_doc_number] => 20110257249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'DRUG CARRIERS' [patent_app_type] => utility [patent_app_number] => 13/170967 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18772 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257249.pdf [firstpage_image] =>[orig_patent_app_number] => 13170967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883630 [patent_doc_number] => 20130156814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/704978 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 76997 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629915 [patent_doc_number] => 08361986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Synthetic agonists of TLR9' [patent_app_type] => utility [patent_app_number] => 13/156140 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 10657 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13156140 [rel_patent_id] =>[rel_patent_doc_number] =>)